Erratum: Vol. 58, No. RR-2
In the report, "Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," an error occurred in a confidence interval in the last sentence of the fourth paragraph on page 6. The sentence should read, "Among the limited number of infants from phase III trials who received at least 1 dose of RV5 (n = 144) or placebo (n = 135) >10 weeks after a previous dose, the estimate of efficacy of the RV5 series for protection against G1--G4 rotavirus gastroenteritis of any severity was 63% (CI = -53%--94%) (94)."
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to email@example.com.